Programmatic & finance policies

Co-financing means that countries contribute to the cost of GAVI-supported vaccines by procuring some of the required vaccine doses with non-GAVI funds. The level of required co-financing takes into account a country’s ability to pay and is dependent on its income (GNI) per capita.

GAVI aims to focus its funding support on the world’s poorest countries most in need of support. Eligibility is therefore determined by national income with all countries with a Gross National Income (GNI) per capita below or equal to US$1,520 (according to World Bank data for the latest available year) qualifying for support. Under the revised eligibility policy, there are currently 57 “GAVI-eligible” countries.

The GAVI Alliance gender policy recognises equal access to immunisation as a key factor in ensuring expanded, equitable vaccine coverage and strengthened health services.

GAVI aims to focus its support on the poorest countries. Therefore, countries whose Gross National Income (GNI) per capita crosses the GAVI eligibility threshold (currently US$1,520) enter a graduation process and are no longer eligible to apply for new GAVI funding.

In June 2010, the GAVI Board approved a mechanism which allows the ranking of technically sound proposals from GAVI-eligible countries and the subsequent prioritisation of funding choices.

On 1 January 2009, GAVI enacted a new Transparency & Accountability Policy (TAP) that aims at managing fiduciary risk in GAVI-supported countries.

Donations of vaccines by industry to international organisations or to governments can bring benefits if properly managed, but also carry certain risks. GAVI only accepts vaccines donations under exceptional circumstances and requires both the manufacturer and recipient country to comply with a number of conditions.